David Shaw’s GP-Act III Acquisition Corp GPAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,423,125
Closed -$15.4M 5296
2026
Q1
$15.4M Hold
1,423,125
0.01% 1322
2025
Q4
$15.2M Hold
1,423,125
0.01% 1424
2025
Q3
$15.1M Hold
1,423,125
0.01% 1375
2025
Q2
$15M Buy
1,423,125
+185,625
+15% +$1.94M 0.01% 1219
2025
Q1
$12.8M Hold
1,237,500
0.01% 1221
2024
Q4
$12.6M Buy
1,237,500
+377,727
+44% +$3.81M 0.01% 1337
2024
Q3
$8.67M Buy
+859,773
New +$8.62M 0.01% 1518

Other funds holding GPAT

David Shaw's GPAT Position: Q2 2026 in Review

David Shaw sold out of GP-Act III Acquisition Corp (GPAT) in Q2 2026, closing a stake of 1,423,125 shares — an estimated $15.4M sold.

David Shaw first reported a position in GPAT in Q3 2024 and held it in 7 quarters. The position peaked at $15.4M in Q1 2026. 24 funds tracked by Wall St. Rank hold GPAT as of Q2 2026.

  • David Shaw reported no remaining GP-Act III Acquisition Corp position as of Q2 2026 after selling out during the quarter.
  • David Shaw sold 1,423,125 GP-Act III Acquisition Corp shares in Q2 2026, an estimated $15.4M.
  • David Shaw first reported a position in GP-Act III Acquisition Corp in Q3 2024 and held it in 7 quarters.
  • David Shaw's GP-Act III Acquisition Corp position peaked at $15.4M in Q1 2026.
  • 24 funds tracked by Wall St. Rank held GP-Act III Acquisition Corp as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.